BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,000 | -12.5% | 2,100 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -89.9% | 2,100 | -89.8% | 0.00% | – |
| Q1 2021 | $79,000 | -17.7% | 20,678 | -2.7% | 0.00% | – |
| Q4 2020 | $96,000 | -63.8% | 21,249 | +35.5% | 0.00% | – |
| Q3 2020 | $265,000 | +73.2% | 15,683 | +15.0% | 0.00% | – |
| Q2 2020 | $153,000 | +920.0% | 13,640 | +286.8% | 0.00% | – |
| Q4 2019 | $15,000 | -84.0% | 3,526 | -88.2% | 0.00% | – |
| Q1 2018 | $94,000 | -75.6% | 29,912 | -69.7% | 0.00% | – |
| Q4 2017 | $386,000 | +310.6% | 98,590 | +330.0% | 0.00% | – |
| Q3 2017 | $94,000 | – | 22,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |